Ignite Creation Date:
2025-12-24 @ 2:07 PM
Ignite Modification Date:
2026-01-24 @ 2:42 AM
Study NCT ID:
NCT00980395
Status:
COMPLETED
Last Update Posted:
2019-12-30
First Post:
2009-09-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma
Sponsor:
University of Arizona
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent mantle cell lymphoma | View |
| None | stage III mantle cell lymphoma | View |
| None | stage IV mantle cell lymphoma | View |
| None | recurrent marginal zone lymphoma | View |
| None | stage III marginal zone lymphoma | View |
| None | stage IV marginal zone lymphoma | View |
| None | Waldenstrom macroglobulinemia | View |
| None | recurrent small lymphocytic lymphoma | View |
| None | stage III small lymphocytic lymphoma | View |
| None | stage IV small lymphocytic lymphoma | View |
| None | recurrent grade 1 follicular lymphoma | View |
| None | recurrent grade 2 follicular lymphoma | View |
| None | recurrent grade 3 follicular lymphoma | View |
| None | stage III grade 1 follicular lymphoma | View |
| None | stage III grade 2 follicular lymphoma | View |
| None | stage III grade 3 follicular lymphoma | View |
| None | stage IV grade 1 follicular lymphoma | View |
| None | stage IV grade 2 follicular lymphoma | View |
| None | stage IV grade 3 follicular lymphoma | View |
| None | extranodal marginal zone BCL mucosa assoc lymphoid tissue | View |
| None | nodal marginal zone B Cell lymphoma | View |
| None | splenic marginal zone lymphoma | View |